Page 32 - AN-1-3
P. 32

Advanced Neurology                                               Inflammation and gut microbiota in depression



            systemic inflammation in patients with Parkinson’s   ultimately leading to cognitive impairment . Indeed,
                                                                                                    [40]
            disease , while  Blautia species may be associated with   the levels of serum lgA and IgM against the LPS of
                 [30]
            good cognition and decreased inflammation in hepatic   enterobacteria have been found to be significantly higher
            encephalopathy . In a study, the transplantation of   in MDD patients than in control subjects . In addition,
                                                                                                 [23]
                        [31]
            gut microbiota from patients with rheumatoid arthritis   a study has found elevated expressions of gut microbial
            activated an abnormal differentiation of T cells in   16S rRNA subunit in the blood plasma of MDD patients
            germ-free (GF) mice, thereby inducing depression-like   compared to healthy controls .
                                                                                      [25]
            behavior . Moreover, two animal studies have shown that   Despite the conflicting results, there is a general
                   [32]
            fecal microbiota transplantation from MDD patients to GF   consensus that MDD patients have abnormal levels of pro-
            mice or microbiota-depleted rats can induce depression-  inflammatory cytokines in the peripheral circulation .
                                                                                                           [41]
            like behaviors, thus elucidating the role of the pro-  Alvarez-Mon  et al. have reported that MDD patients
            inflammatory species of gut microbiota in the pathology   have abnormally functioning CD4  T lymphocytes with
                                                                                           +
            of depression [28,33] . Consistently, the transplantation of fecal   increased levels of circulating IL-17 and TNF-α . Pro-
                                                                                                       [42]
            microbiota from NOD-like receptor protein 3 (NLRP3)   inflammatory cytokines can activate the hypothalamic-
            knock-out (KO) mice reduced the depression-like behavior   pituitary-adrenal (HPA) axis in MDD, leading to elevated
            induced by chronic unpredictable stress in recipient mice   cortisol levels and glucocorticoid receptor resistance .
                                                                                                           [43]
            in our previous study, which was found to be related   Furthermore, the pro-inflammatory cytokines released
            to the changes in the relative abundance of  Firmicutes,   from microglia (e.g., TNF-α) can reduce the levels of
            Proteobacteria, and Bacteroidetes phyla . However, due to   neurotransmitters such as serotonin, dopamine, and
                                           [34]
            large individual variability, methodological heterogeneity,   norepinephrine in MDD patients via several ways, one
            and dietary diversity, we are only beginning to fully                                  [44]
            understand the implications of the gut microbiome on   of which includes reducing their synthesis . Different
                                                               types of immune cells, such as T cells, produce, store,
            human mental health and neuropsychiatric disorders .
                                                      [35]
                                                               and respond to serotonin, which is associated with mood
            3. Inflammatory pathways across the gut-           disorders [45,46] .  In MDD patients,  the persistence  of  pro-
            brain axis                                         inflammatory cytokines (e.g., TNF-α and IL-1β) can
                                                               impair the BBB function . Under stress conditions, BBB
                                                                                   [47]
            3.1. Systemic circulation pathway                  impairments may lead to the infiltration of immune cells.
                                                               It has been shown that T cells and monocytes infiltrate the
            Inflammation has been widely discussed in reviews of   brain under stress. In depressed mice models, T helper
            brain diseases involving the gut-brain axis, such as the   17 cells accumulate in different brain regions, such as the
            interaction  of  central  nervous  system  (CNS)-resident   hippocampus, promoting depression-like behaviors [48,49] .
            and peripheral immune pathways , the relationship
                                         [36]
            between inflammasome and gut microbiota , as         Byproducts of the gut microbiota can play a
                                                    [37]
            well as the crosstalk between neuroinflammation and   neuroimmunomodulatory  role  in  neurological
            peripheral inflammatory mediators . The cytokine   disorders . For example, in a study, the gut microbiome
                                                                      [14]
                                           [38]
            hypothesis suggests that physiological pathways involved   from an aged donor was found to be sufficient to reduce
            in inflammation and stress responses may play a key role   the  host  SCFAs  and  induce  cognitive  decline .  SCFAs
                                                                                                     [50]
            in the pathology of depression. The stress-induced chronic   (primarily acetate, propionate, and butyrate), derived
            low-grade cytokine release in depression drives the overall   from gut bacterial fermentation of non-digestible
            immune response toward proinflammation rather than   carbohydrates, have been reported to be present in human
                                                                            [51]
            anti-inflammation. The pro-inflammatory mediators in   CSF  and blood .  It is  believed  that  systemic  SCFAs
            the circulation disrupt both epithelial and endothelial   can cross the BBB and regulate BBB permeability and
            tight junctions, compromising the integrity of the gut-  microglia functions. For example, a study has found that
            vascular barrier and the BBB . This leads to an increase   oral SCFAs can ameliorate depression-like behaviors in
                                   [39]
            in intestinal permeability (leaky gut) and a disrupted CNS   mice exposed to chronic stress, which is associated with
            barrier, providing a gateway for food antigens, toxins, and   the inhibition of hippocampal neurogenesis decline, BBB
            pathogens from the gut to reach the brain, followed by the   damage, microglia activation, and neuroinflammation by
            activation of neuroimmune cells, which in turn triggers   SCFAs . Tryptophan metabolites that are derived from
                                                                    [52]
            neuroinflammation . For example, the increased systemic   gut microbiota represent another example of the gut-brain
                           [39]
            inflammation and subsequent neuroinflammation caused   axis in the regulation of host inflammatory responses.
            by the intraperitoneal injection of bacterial endotoxin   A study has shown that tryptophan, metabolized by the gut
            LPS mediate microglia activation and neuronal cell death,   microbiota, can activate aryl hydrocarbon receptor (AhR)


            Volume 1 Issue 3 (2022)                         4                       https://doi.org/10.36922/an.v1i3.272
   27   28   29   30   31   32   33   34   35   36   37